Skip to Main Content

Author Details

Bernhard Hemmer
Technical University of Munich
1995
411
83
PMIDPaper TitleJournal TitlePublished Year
36319190Association of obesity with disease outcome in multiple sclerosis.J Neurol Neurosurg Psychiatry2023
36245037Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD).J Neurol2023
36205793Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis.J Neurol2023
36319190Association of obesity with disease outcome in multiple sclerosis.J Neurol Neurosurg Psychiatry2023
36427289Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume.Ann Clin Transl Neurol2023
36413917Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants.Mult Scler Relat Disord2023
36411388Exome-based gene panel analysis in a cohort of acute juvenile ischemic stroke patients:relevance of NOTCH3 and GLA variants.J Neurol2023
37564830Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.Brain Commun2023
37479377Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.Lancet Neurol2023
36719741Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.J Clin Invest2023
36635219Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.Eur J Neurol2023
36873454CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype.Front Neurol2023
36623350Lesion location across diagnostic regions in multiple sclerosis.Neuroimage Clin2023
37051911Bony Stroke: Ischemic Stroke Caused by Mechanical Stress on Brain Supplying Arteries From Anatomical Bone or Cartilage Anomalies.Stroke2023
36993939Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis.Ther Adv Neurol Disord2023
36689214Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial.JAMA Neurol2023
37114068The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study.Ther Adv Neurol Disord2023
37294304[Ocrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?]Nervenarzt2023
37293849European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.Eur J Neurol2023
37293841ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.Mult Scler2023
37495267Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis.J Neurol Neurosurg Psychiatry2023
37479377Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.Lancet Neurol2023
37495267Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis.J Neurol Neurosurg Psychiatry2023
37564830Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.Brain Commun2023
37051911Bony Stroke: Ischemic Stroke Caused by Mechanical Stress on Brain Supplying Arteries From Anatomical Bone or Cartilage Anomalies.Stroke2023
37114068The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study.Ther Adv Neurol Disord2023
37294304[Ocrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?]Nervenarzt2023
37293849European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.Eur J Neurol2023
37293841ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.Mult Scler2023
36993939Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis.Ther Adv Neurol Disord2023
36623350Lesion location across diagnostic regions in multiple sclerosis.Neuroimage Clin2023
36719741Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.J Clin Invest2023
36689214Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial.JAMA Neurol2023
36873454CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype.Front Neurol2023
36427289Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume.Ann Clin Transl Neurol2023
36635219Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.Eur J Neurol2023
36413917Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants.Mult Scler Relat Disord2023
36411388Exome-based gene panel analysis in a cohort of acute juvenile ischemic stroke patients:relevance of NOTCH3 and GLA variants.J Neurol2023
36245037Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD).J Neurol2023
36205793Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis.J Neurol2023
33179588Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms.Mult Scler2022
36049213Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort.J Neuroophthalmol2022
35840705From the prodromal stage of multiple sclerosis to disease prevention.Nat Rev Neurol2022
35764402The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.Neurology2022
35704066[The anti-IgLON5 syndrome in clinical neurology-Report of two cases].Nervenarzt2022
35821382P2R Inhibitors Prevent Antibody-Mediated Complement Activation in an Animal Model of Neuromyelitis Optica : P2R Inhibitors Prevent Autoantibody Injury.Neurotherapeutics2022
36439131Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis.Front Immunol2022
36384926Toscana Virus Meningoencephalitis in Upper Bavaria.Dtsch Arztebl Int2022
35468568Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.Neuroimage Clin2022
34259579Optical coherence tomography angiography indicates subclinical retinal disease in neuromyelitis optica spectrum disorders.Mult Scler2022
  • 1 - 50 of 822

Recommended Authors

University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Columbia University Medical Center
Career Start Year 2012
Number of shared co-authors 3
Institute of Medicine, University of Tsukuba
Career Start Year 2011
Number of shared co-authors 2
University of Virginia Medical Center
Career Start Year 2008
Number of shared co-authors 0
University of Illinois College of Medicine Rockford
Career Start Year 2007
Number of shared co-authors 2
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 1
Uppsala University
Career Start Year 2007
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 2007
Number of shared co-authors 2
University of California san francisco
Career Start Year 2006
Number of shared co-authors 3
Yale University
Career Start Year 2005
Number of shared co-authors 9
University of Pittsburgh
Career Start Year 2004
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 3
Weill Institute for Neurosciences, University of California-San Francisco
Career Start Year 2001
Number of shared co-authors 5
Roche Pharma Research and Early Development
Career Start Year 1999
Number of shared co-authors 0
Concord Repatriation General Hospital
Career Start Year 1998
Number of shared co-authors 9
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
University of Massachusetts Medical School
Career Start Year 1993
Number of shared co-authors 8
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Department of Pharmaceutical Sciences, State University of New York
Career Start Year 1991
Number of shared co-authors 3
McMaster University
Career Start Year 1991
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 2
Weill Cornell School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Fondazione IRCCS Istituto Neurologico Carlo Besta
Career Start Year 1988
Number of shared co-authors 1
Institute of Inflammation and Ageing, University of Birmingham
Career Start Year 1987
Number of shared co-authors 0
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 21
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 5
Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Career Start Year 1985
Number of shared co-authors 12
Pape Family Pediatric Research Institute, Oregon Health and Science University
Career Start Year 1983
Number of shared co-authors 0
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Co-authored papers 79
Co-authored papers 77
Co-authored papers 51
TUM School of Medicine, Technical University of Munich
Co-authored papers 43
Co-authored papers 37
Technical University of Munich
Co-authored papers 30
Co-authored papers 30
Co-authored papers 29
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 25
Co-authored papers 20
Stanford University School of Medicine
Co-authored papers 17
Co-authored papers 17
Co-authored papers 16
Co-authored papers 14
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Co-authored papers 14
The Ohio State University Wexner Medical Center
Co-authored papers 13
Co-authored papers 12
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 11
Max Planck Institute of Psychiatry
Co-authored papers 11
Co-authored papers 10
Co-authored papers 9
Moorfields Eye Hospital
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Johns Hopkins University School of Medicine
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7